About Us

Conference

Partner With Us

Home
Bioanalytical Services
Top Bioanalytical Service Companies in Europe

Top 10 Bioanalytical Service Companies in Europe - 2022

Alarge number of infectious diseases and increasing cases of chronic diseases has been the key factor in the proliferation of the bioanalytical services market. According to MarketWatch, the global bioanalytical testing services market, worth USD 3.5 billion in 2022, is projected to reach USD 6.1 billion in 2027 at a compounding annual growth rate of 12.1 per cent. Several pharmaceutical organizations are collaborating with research institutes to provide efficient, cost-effective bioanalytical services to meet the increase in demand. Healthcare providers are looking to set up labs on-premise and partner with bioanalytical service providers to improve the efficiency of treatments. Furthermore, access to patients' genomic information is also revolutionizing the bioanalytical industry by providing crucial insights while developing and testing drugs.

In this edition of Life Sciences Review Europe, we present the list of the Top 10 Bioanalytical Services Companies in Europe for the year 2022. GermanOncology GmbH is a prominent company that utilizes its extensive real-world database to assist physicians in devising effective treatment plans for patients through its analysis, consulting, project management, and IT development services. We also bring to you thought leadership articles and exclusive insights from expert CIOs and CXOs - Dave Henderson, CIO, Millennium Health; Stefano Ferrara, Director, Clinical Science, BeiGene, presenting their views and opinions on how organizations can incorporate changes in the bioanalytics industry. We hope the valuable insights from industry thought leaders and the bioanalytics agencies featured in this edition help you make informed decisions for your organization.

Let us know your thoughts!

Top 10 Bioanalytical Service Companies in Europe - 2022

Top Bioanalytical Service Companies in Europe

Read full profile →

GermanOncology GmbH utilizes its extensive real-world database to assist physicians in devising effective treatment plans for patients through its analysis, consulting, project management, and IT development services. ... read full profile

Read full profile →

A&M STABTEST— a specialist in the pharmaceutical analysis of small molecules and biomolecules— offers bioanalytical services solely for the pharmaceutical industry. ... read full profile

Read full profile →

Synexa provides clients with a broad spectrum of analytical and advising services, including biomarker and bioanalytical readout identification, development, validation, analysis, and interpretation in translational and clinical research. Synexa was established in 2003 as a forerunner in the field of biomarker science. ... read full profile

Artialis

Artialis is specialized in the development and clinical application of biomarkers-based immunoassays. Since 2021, Artialis is a niche Contract Research and Development Organization (#CRDO) company offering #preclinical, #clinical and #biotesting services. The company offers customized solutions and supports from preclinical (cell culture models and animal studies) to post-marketing clinical phase and a large panel of clinical, imaging and biochemical markers useful to support drug development

Cerba Research

Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With their global access to leading regional labs, data, patients, technology, and partnered resources, they support global biotech, pharma, and IVD organizations to improve the lives of patients around the world

Intravacc

As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials in humans. They at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines by bridging the gap between your concept and late stage clinical studies

KYMOS Group

The Kymos Group is an analytical CRO with three European laboratories devoted to providing bioanalytical and CMC services for the life science industry throughout the entire product life cycle: from early research and development to manufacturing and comercialization

MedPharm

MedPharm is a world-leading contract provider of topical and transdermal product design and development services. Their delivery of robust and innovative research has commanded recognition from regulators and investors alike. They utilise their unique cost-effective performance testing models to mitigate risk and accelerate development times

Molecular Devices

Molecular Devices is one of the world’s leading providers of high-performance life science technology. They make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high throughput screening, genomic and cellular analysis, colony selection and microplate detection

Nuvisan

The Nuvisan group is a Contract Research Organization (CRO) and Contract Manufacturing Organization (CDMO). Nuvisan offers integrated and coupled services and solutions along the drug development value chain from target identification to the patient with all supporting services (DMPK, GMP synthesis, formulation development and analysis, bioanalysis, Phase 1 CPU, clinical trial supplies and monitoring)